Clinical Effects of Alpha-Lipoic Acid in Advanced NSCLC
NCT07574684
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Advanced Non Small Cell Lung Cancer (NSCLC)
Interventions
DRUG:
Alpha Lipoic Acid 600mg
Sponsor
Ain Shams University